7Baggers

TransMedics Group, Inc
(NASDAQ:TMDX) 

TMDX stock logo

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring...

Founded: 1998
Full Time Employees: 109
CEO: Waleed H. Hassanein  
Sector: Healthcare
Industry: Medical Devices
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 
                                 
      revenue:
    		                             
      net product revenue
    		107,972,000 100,390,000 87,677,000 96,100,000 88,234,000 74,948,000 65,861,000 71,732,000 61,325,000 51,874,000 47,740,000 42,462,000 33,993,000                 
      service revenue
    		65,961,000 60,374,000 56,146,000 61,270,000 55,303,000 46,676,000 42,900,000 42,573,000 35,525,000 29,300,000 18,690,000 10,003,000 7,561,000                 
      total revenue
    		173,933,000 160,764,000 143,823,000 157,370,000 143,537,000 121,624,000 108,761,000 114,305,000 96,850,000 81,174,000 66,430,000 52,465,000 41,554,000 31,375,000 25,683,000 20,521,000 15,880,000 9,668,000 5,370,000 8,171,000 7,053,000 7,627,000 7,091,000 3,391,000 7,530,000 6,057,000 7,205,000 5,666,000 4,676,000 
      yoy
    		21.18% 32.18% 32.24% 37.68% 48.21% 49.83% 63.72% 117.87% 133.07% 158.72% 158.65% 155.66% 161.68% 224.52% 378.27% 151.14% 125.15% 26.76% -24.27% 140.96% -6.33% 25.92% -1.58% -40.15% 61.04%     
      qoq
    		8.19% 11.78% -8.61% 9.64% 18.02% 11.83% -4.85% 18.02% 19.31% 22.19% 26.62% 26.26% 32.44% 22.16% 25.15% 29.23% 64.25% 80.04% -34.28% 15.85% -7.53% 7.56% 109.11% -54.97% 24.32% -15.93% 27.16% 21.17%  
      cost of revenue:
    		                             
      cost of net product revenue
    		24,308,000 23,402,000 18,687,000 19,421,000 16,312,000 16,545,000 13,246,000 14,470,000 14,084,000 14,065,000 11,086,000 8,558,000 7,306,000                 
      cost of service revenue
    		48,464,000 43,948,000 40,561,000 41,360,000 38,997,000 33,066,000 34,670,000 30,574,000 22,804,000 19,185,000 14,682,000 7,166,000 5,482,000                 
      total cost of revenue
    		72,772,000 67,350,000 59,248,000 60,781,000 55,309,000 49,611,000 47,916,000 45,044,000 36,888,000 33,250,000 25,768,000 15,724,000 12,788,000 10,672,000 7,568,000 6,171,000 3,776,000 2,682,000 1,597,000 2,582,000 2,242,000 2,799,000 2,053,000 1,482,000 2,670,000 2,316,000 2,989,000 2,333,000 2,103,000 
      gross profit
    		101,161,000 93,414,000 84,575,000 96,589,000 88,228,000 72,013,000 60,845,000 69,261,000 59,962,000 47,924,000 40,662,000 36,741,000 28,766,000 20,703,000 18,115,000 14,350,000 12,104,000 6,986,000 3,773,000 5,589,000 4,811,000 4,828,000 5,038,000 1,909,000 4,860,000 3,741,000 4,216,000 3,333,000 2,573,000 
      yoy
    		14.66% 29.72% 39.00% 39.46% 47.14% 50.27% 49.64% 88.51% 108.45% 131.48% 124.47% 156.03% 137.66% 196.35% 380.12% 156.75% 151.59% 44.70% -25.11% 192.77% -1.01% 29.06% 19.50% -42.72% 88.88%     
      qoq
    		8.29% 10.45% -12.44% 9.48% 22.52% 18.35% -12.15% 15.51% 25.12% 17.86% 10.67% 27.72% 38.95% 14.29% 26.24% 18.56% 73.26% 85.16% -32.49% 16.17% -0.35% -4.17% 163.91% -60.72% 29.91% -11.27% 26.49% 29.54%  
      gross margin %
    		58.16% 58.11% 58.80% 61.38% 61.47% 59.21% 55.94% 60.59% 61.91% 59.04% 61.21% 70.03% 69.23% 65.99% 70.53% 69.93% 76.22% 72.26% 70.26% 68.40% 68.21% 63.30% 71.05% 56.30% 64.54% 61.76% 58.51% 58.82% 55.03% 
      operating expenses:
    		                             
      research, development and clinical trials
    		24,879,000 20,701,000 15,260,000 15,934,000 17,160,000 16,464,000 14,266,000 13,858,000 11,380,000 10,761,000 11,132,000 8,291,000 5,871,000 5,756,000 6,808,000 6,714,000 7,534,000 6,314,000 5,163,000 6,295,000 4,532,000 4,548,000 4,155,000 3,903,000 6,225,000 6,262,000 4,939,000 4,787,000 3,882,000 
      selling, general and administrative
    		62,985,000 51,440,000 46,015,000 44,088,000 43,625,000 46,905,000 42,656,000 42,895,000 36,161,000 34,560,000 30,653,000 29,356,000 24,984,000 21,726,000 16,851,000 17,381,000 13,939,000 12,000,000 10,335,000 9,162,000 6,786,000 6,176,000 5,493,000 5,867,000 6,652,000 6,173,000 6,519,000 6,251,000 4,653,000 
      total operating expenses
    		87,864,000 72,141,000 61,275,000 60,022,000 60,785,000 63,369,000 56,922,000 56,753,000 47,541,000 45,321,000 68,997,000 37,647,000 30,855,000 27,482,000 23,659,000 24,095,000 21,473,000 18,314,000 15,498,000 15,457,000 11,318,000 10,724,000 9,648,000 9,770,000 12,877,000 12,435,000 11,458,000 11,038,000 8,535,000 
      income from operations
    		13,297,000 21,273,000 23,300,000 36,567,000 27,443,000 8,644,000 3,923,000 12,508,000 12,421,000 2,603,000 -28,335,000 -906,000 -2,089,000 -6,779,000 -5,544,000 -9,745,000 -9,369,000 -11,328,000 -11,725,000 -9,868,000 -6,507,000 -5,896,000 -4,610,000 -7,861,000 -8,017,000 -8,694,000 -7,242,000 -7,705,000 -5,962,000 
      yoy
    		-51.55% 146.10% 493.93% 192.35% 120.94% 232.08% -113.85% -1480.57% -694.59% -138.40% 411.09% -90.70% -77.70% -40.16% -52.72% -1.25% 43.98% 92.13% 154.34% 25.53% -18.83% -32.18% -36.34% 2.02% 34.47%     
      qoq
    		-37.49% -8.70% -36.28% 33.25% 217.48% 120.34% -68.64% 0.70% 377.18% -109.19% 3027.48% -56.63% -69.18% 22.28% -43.11% 4.01% -17.29% -3.39% 18.82% 51.65% 10.36% 27.90% -41.36% -1.95% -7.79% 20.05% -6.01% 29.24%  
      operating margin %
    		7.64% 13.23% 16.20% 23.24% 19.12% 7.11% 3.61% 10.94% 12.82% 3.21% -42.65% -1.73% -5.03% -21.61% -21.59% -47.49% -59.00% -117.17% -218.34% -120.77% -92.26% -77.30% -65.01% -231.82% -106.47% -143.54% -100.51% -135.99% -127.50% 
      other income:
    		                             
      interest expense
    		-7,170,000 -3,354,000 -3,491,000 -3,476,000 -3,461,000 -3,571,000 -3,617,000 -3,623,000 -3,598,000 -3,605,000 -3,590,000 -2,505,000 -1,091,000 -1,007,000 -787,000 -972,000 -960,000 -978,000 -979,000 -965,000 -952,000 -971,000 -971,000 -1,001,000 -1,042,000 -1,063,000 -1,084,000 -1,113,000 -1,093,000 
      interest income and other income
    		2,358,000 3,714,000 3,222,000 3,091,000 2,694,000 1,916,000 3,939,000 3,268,000 3,570,000                     
      total other expense
    		-4,812,000   -385,000 -767,000   -355,000 -28,000   -74,000 -536,000 78,000 -1,863,000 -1,756,000 -1,187,000 -1,323,000 -1,228,000 -794,000 -1,406,000 -405,000 -472,000 -630,000 -825,000 -473,000 -1,028,000 -1,480,000 -923,000 
      income before income taxes
    		8,485,000 21,633,000 23,031,000 36,182,000 26,676,000 6,989,000 4,245,000 12,153,000 12,393,000 3,863,000 -26,929,000 -980,000 -2,625,000 -6,701,000 -7,407,000 -11,501,000 -10,556,000 -12,651,000 -12,953,000 -10,662,000 -7,913,000 -6,301,000 -5,082,000 -8,491,000 -8,842,000 -9,167,000 -8,270,000 -9,185,000 -6,885,000 
      provision for income taxes
    		-1,170,000    -994,000    -196,000   -21,000 -11,000 -19,000 -19,000 -22,000 -6,000 -17,000 -9,000 -6,000 -4,000 -10,000 -6,000 -6,000 -10,000 -10,000 -10,000 -10,000 -10,000 
      net income
    		7,315,000 105,383,000 24,319,000 34,907,000 25,682,000 6,857,000 4,216,000 12,194,000 12,197,000 4,031,000 -25,422,000 -1,001,000 -2,636,000 -6,720,000 -7,426,000 -11,523,000 -10,562,000 -12,668,000 -12,962,000 -10,668,000 -7,917,000 -6,311,000 -5,088,000 -8,497,000 -8,852,000 -9,177,000 -8,280,000 -9,195,000 -6,895,000 
      yoy
    		-71.52% 1436.87% 476.83% 186.26% 110.56% 70.11% -116.58% -1318.18% -562.71% -159.99% 242.34% -91.31% -75.04% -46.95% -42.71% 8.01% 33.41% 100.73% 154.76% 25.55% -10.56% -31.23% -38.55% -7.59% 28.38%     
      qoq
    		-93.06% 333.34% -30.33% 35.92% 274.54% 62.64% -65.43% -0.02% 202.58% -115.86% 2439.66% -62.03% -60.77% -9.51% -35.55% 9.10% -16.62% -2.27% 21.50% 34.75% 25.45% 24.04% -40.12% -4.01% -3.54% 10.83% -9.95% 33.36%  
      net income margin %
    		4.21% 65.55% 16.91% 22.18% 17.89% 5.64% 3.88% 10.67% 12.59% 4.97% -38.27% -1.91% -6.34% -21.42% -28.91% -56.15% -66.51% -131.03% -241.38% -130.56% -112.25% -82.75% -71.75% -250.58% -117.56% -151.51% -114.92% -162.28% -147.46% 
      net income per share
    		         0.12 -0.78 -0.03 -0.08 -0.2 -0.25 -0.41 -0.38 -0.46 -0.47 -0.39 -0.29 -0.22 -0.19 -0.36 -0.42 -0.31 -0.39 -0.7 -4.86 
      basic
    		0.21 3.1 0.71 1.03 0.76 0.21 0.13 0.37 0.37                     
      diluted
    		0.2 2.59 0.66 0.92 0.7 0.2 0.12 0.35 0.35                     
      weighted-average common shares outstanding:
    		                             
      basic
    		34,384,207 33,993,468 34,112,452 33,912,669 33,721,603 33,229,953 33,441,394 33,119,514 32,760,190                     
      diluted
    		36,194,023 40,540,694 40,748,023 40,558,953 39,914,487 35,216,837 35,683,952 35,288,308 34,678,895                     
      total other income
    		 360,000 -269,000   -1,655,000 322,000   1,260,000 1,406,000                   
      benefit for income taxes
    		 83,750,000 1,288,000 -1,275,000  -132,000 -29,000 41,000  168,000 1,507,000                   
      acquired in-process research and development expenses
    		          27,212,000                   
      other income
    		         4,865,000 4,996,000 2,431,000 555,000   -784,000  -345,000 -249,000 171,000 -454,000 566,000 499,000 371,000 217,000 590,000 56,000 247,000 -103,000 
      net income per share
    		         0.12 -0.78 -0.03 -0.08 -0.2 -0.25 -0.41 -0.38 -0.46 -0.47 -0.39 -0.29 -0.22 -0.19 -0.36 -0.42 -0.31 -0.39 -0.7 -4.86 
      weighted-average common shares outstanding, basic and diluted
    		         32,517,372 32,614,059 32,545,352 32,260,267 29,556,633 30,229,936 27,983,629 27,950,330 27,616,839 27,701,252 27,620,764 27,368,090 24,702,764 27,156,135 23,330,918 21,221,385 14,204,787 21,131,618 13,133,834 1,418,353 
      other expense
    		             -521,750 -1,076,000  -227,000             
      change in fair value of preferred stock warrant liability
    		                           -614,000 273,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 
                                   
        assets
      		                             
        current assets:
      		                             
        cash
      		461,739,000 488,366,000 466,174,000 400,575,000 310,143,000 336,650,000 330,094,000 362,751,000 350,217,000 394,812,000 427,110,000 582,210,000 195,375,000                 
        accounts receivable
      		90,727,000 84,282,000 80,702,000 104,851,000 142,026,000 97,722,000 90,128,000 81,158,000 81,942,000 63,576,000 60,654,000 47,524,000 38,620,000 27,611,000 22,035,000 12,979,000 11,724,000 5,934,000 4,150,000 6,271,000 7,395,000 6,864,000 6,141,000 4,431,000 6,133,000   7,105,000 5,146,000 
        inventory
      		49,890,000 48,881,000 44,506,000 38,868,000 43,380,000 46,554,000 52,152,000 48,671,000 48,541,000 44,235,000 39,365,000 30,545,000 23,961,000 20,605,000 18,575,000 17,468,000 16,714,000 14,859,000 14,869,000 13,007,000 11,820,000 11,934,000 12,984,000 12,555,000 11,361,000 11,216,000 10,536,000 11,220,000 11,294,000 
        prepaid expenses and other current assets
      		16,924,000 16,254,000 21,614,000 13,835,000 10,369,000 16,290,000 20,101,000 16,685,000 7,606,000 8,031,000 9,595,000 2,376,000 3,774,000 2,896,000 5,514,000 6,583,000 5,356,000 5,460,000 3,703,000 3,525,000 3,215,000 2,326,000 2,287,000 1,866,000 1,656,000 1,538,000 2,093,000 1,571,000 1,404,000 
        total current assets
      		619,280,000 637,783,000 612,996,000 558,129,000 505,918,000 497,216,000 492,475,000 509,265,000 488,306,000 510,654,000 536,724,000 662,655,000 261,730,000 252,294,000 250,586,000 95,113,000 105,795,000 118,705,000 125,577,000 135,052,000 140,543,000 146,766,000 154,126,000 158,227,000 91,704,000 100,001,000 107,366,000 116,133,000 30,059,000 
        property, plant and equipment
      		361,571,000 327,656,000 313,022,000 312,255,000 311,244,000 285,970,000 271,739,000 229,030,000 214,421,000 173,941,000 131,004,000                   
        finance lease right-of-use assets
      		334,545,000                             
        operating lease right-of-use assets
      		4,858,000 5,155,000 5,740,000 5,818,000 6,007,000 6,481,000 6,943,000 5,896,000 6,226,000 6,546,000 6,861,000 6,929,000 4,939,000 5,130,000 5,315,000 5,495,000 5,669,000 5,847,000            
        deferred tax assets
      		82,476,000 83,543,000                            
        restricted cash
      		18,438,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 750,000 750,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 
        goodwill
      		11,549,000 11,549,000 11,549,000 11,549,000 11,549,000 11,549,000 11,549,000 11,549,000 11,990,000 11,990,000 11,673,000                   
        acquired intangible assets
      		 1,948,000 1,999,000 2,050,000 2,101,000 2,152,000 2,202,000 2,253,000 2,303,000 2,354,000 2,405,000                   
        other non-current assets
      		2,103,000 239,000 226,000 221,000 211,000 208,000 163,000 84,000 85,000 62,000 60,000 59,000 508,000                 
        total assets
      		1,434,820,000 1,068,373,000 946,032,000 890,522,000 837,530,000 804,076,000 785,571,000 758,577,000 723,831,000 706,047,000 689,227,000 690,358,000 287,088,000 277,147,000 274,873,000 117,285,000 124,008,000 134,893,000 131,146,000 140,512,000 145,783,000 152,026,000 159,322,000 163,137,000 96,923,000 105,299,000 112,618,000 121,014,000 38,759,000 
        liabilities and stockholders’ equity
      		                             
        current liabilities:
      		                             
        accounts payable
      		11,151,000 10,350,000 12,162,000 9,539,000 10,595,000 10,292,000 13,134,000 13,027,000 9,225,000 12,717,000 12,836,000 7,031,000 4,329,000 3,341,000 3,080,000 5,711,000 2,934,000 6,651,000 2,682,000 2,389,000 1,289,000 1,206,000 778,000 3,722,000 4,860,000 7,247,000 4,766,000 6,662,000 5,499,000 
        accrued expenses and other current liabilities
      		59,316,000 62,740,000 56,016,000 42,490,000 40,139,000 45,152,000 42,187,000 37,716,000 36,852,000 38,221,000 31,651,000 22,862,000 22,581,000 18,635,000 15,976,000 15,420,000 15,738,000 16,337,000 12,769,000 12,100,000 9,931,000 10,317,000 11,474,000 8,858,000 9,926,000 8,332,000 9,348,000 8,180,000 9,989,000 
        current portion of long-term debt
      		15,000,000 10,000,000 5,000,000                           
        deferred revenue
      		2,945,000 2,905,000 3,305,000 1,570,000 2,078,000 1,742,000 2,184,000 1,447,000 2,060,000 1,961,000 2,629,000 244,000 244,000 241,000 226,000 238,000 247,000 250,000 320,000 473,000 432,000 263,000 1,347,000 1,020,000 164,000 166,000 162,000 175,000 359,000 
        operating lease liabilities
      		3,508,000 3,310,000 3,238,000 3,021,000 2,791,000 2,727,000 2,543,000 2,139,000 2,086,000 2,035,000 1,985,000 1,880,000 1,481,000 1,444,000 1,407,000 1,372,000 1,337,000             
        total current liabilities
      		91,920,000 89,305,000 79,721,000 56,620,000 55,603,000 59,913,000 60,048,000 54,329,000 50,223,000 54,934,000 49,101,000 32,017,000 28,635,000 23,661,000 20,689,000 22,741,000 20,256,000 23,238,000 15,923,000 15,079,000 11,757,000 11,879,000 13,624,000 13,818,000 15,039,000 16,115,000 14,641,000 15,377,000 16,201,000 
        convertible senior notes
      		453,530,000 452,804,000 452,082,000 451,364,000 450,650,000 449,939,000 449,237,000 448,534,000 447,835,000 447,140,000 446,448,000 445,761,000                  
        long-term debt
      		44,665,000 49,587,000 54,603,000 59,525,000 59,448,000 59,372,000 59,294,000 59,217,000 59,141,000 59,064,000 58,986,000 58,908,000 58,802,000 58,696,000 58,540,000 35,475,000 35,334,000 35,197,000 35,058,000 34,921,000 34,787,000 34,657,000 34,525,000 34,395,000 34,269,000 34,146,000 34,023,000 33,902,000 33,785,000 
        finance lease liability
      		343,829,000                             
        operating lease liabilities, net of current portion
      		2,883,000 3,577,000 4,426,000 4,912,000 5,521,000 6,249,000 7,072,000 6,603,000 7,161,000 7,707,000 8,232,000 8,459,000 7,026,000 7,415,000 7,787,000 8,150,000 8,508,000 8,604,000            
        other long-term liabilities
      		3,986,000                             
        total liabilities
      		940,813,000 595,273,000 590,832,000 572,421,000 571,222,000 575,473,000 575,651,000 568,683,000 564,360,000 568,845,000 562,767,000 545,145,000 94,463,000 89,772,000 87,016,000 66,366,000 64,098,000 67,039,000 52,597,000 51,529,000 48,108,000 48,135,000 49,772,000 49,377,000 50,240,000 50,650,000 49,146,000 49,853,000 51,278,000 
        commitments and contingencies
      		                             
        stockholders’ equity:
      		                             
        preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding
      		                             
        common stock
      		764,640,000 750,926,000 738,432,000 725,655,000 709,194,000 697,208,000 685,251,000 669,445,000 651,161,000 641,106,000 634,458,000 627,747,000 674,156,000 666,277,000 660,061,000 515,756,000 513,203,000 510,488,000 508,458,000 505,933,000 503,912,000 502,217,000 501,486,000 500,556,000 424,791,000 424,134,000 423,758,000 423,245,000  
        accumulated other comprehensive income
      		2,000 124,000 101,000 98,000                    36,000 227,000 -2,000 20,000   
        accumulated deficit
      		-270,635,000 -277,950,000 -383,333,000 -407,652,000 -442,559,000 -468,241,000 -475,098,000 -479,314,000 -491,508,000 -503,705,000 -507,736,000 -482,314,000 -481,313,000 -478,677,000 -471,957,000 -464,531,000 -453,008,000 -442,446,000 -429,778,000 -416,816,000 -406,148,000 -398,231,000 -391,920,000 -386,832,000 -378,335,000 -369,483,000 -360,306,000 -352,026,000 -342,831,000 
        total stockholders’ equity
      		494,007,000             187,375,000    67,854,000    103,891,000   46,683,000 54,649,000 63,472,000 71,161,000  
        total liabilities and stockholders’ equity
      		1,434,820,000             277,147,000    134,893,000    152,026,000   96,923,000     
        liabilities and stockholders' equity
      		                             
        stockholders' equity:
      		                             
        total stockholders' equity
      		 473,100,000 355,200,000 318,101,000 266,308,000 228,603,000 209,920,000 189,894,000 159,471,000 137,202,000 126,460,000 145,213,000 192,625,000  187,857,000 50,919,000 59,910,000  78,549,000 88,983,000 97,675,000  109,550,000 113,760,000      
        total liabilities and stockholders' equity
      		 1,068,373,000 946,032,000 890,522,000 837,530,000 804,076,000 785,571,000 758,577,000 723,831,000 706,047,000 689,227,000 690,358,000 287,088,000  274,873,000 117,285,000 124,008,000  131,146,000 140,512,000 145,783,000  159,322,000 163,137,000      
        accumulated other comprehensive loss
      		    -327,000 -364,000 -233,000 -237,000 -182,000 -199,000 -262,000 -220,000 -218,000 -225,000 -247,000 -306,000 -285,000 -188,000 -131,000 -134,000 -89,000 -95,000 -16,000     -58,000 -67,000 
        property and equipment
      		           19,965,000 19,161,000 19,223,000 18,472,000 16,177,000 12,044,000 9,841,000 5,063,000 4,954,000 4,734,000 4,754,000 4,690,000 4,404,000 4,713,000 4,792,000 4,746,000 4,375,000 3,750,000 
        cash and cash equivalents
      		             201,182,000 204,462,000 30,386,000 17,897,000 25,580,000 22,495,000 25,314,000 26,727,000 24,581,000 21,397,000 51,152,000 24,738,000 20,092,000 20,407,000 47,242,000 12,215,000 
        marketable securities
      		               27,697,000 54,104,000 66,872,000 80,360,000 86,935,000 91,386,000 101,061,000 111,317,000 88,223,000 47,816,000 60,596,000 67,865,000 48,995,000  
        other long-term assets
      		                  6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 6,000 
        deferred rent, net of current portion
      		                  1,616,000 1,529,000 1,564,000 1,599,000 1,623,000 1,164,000 932,000 389,000 482,000 574,000 667,000 
        current portion of deferred rent
      		                  152,000 117,000 105,000 93,000 25,000 218,000 89,000 370,000 365,000 360,000 354,000 
        accounts receivable, net of 0 allowance
      		                         6,559,000 6,465,000   
        deferred offering costs
      		                            4,444,000 
        liabilities, convertible preferred stock and stockholders’ deficit
      		                             
        preferred stock warrant liability
      		                            625,000 
        convertible preferred stock (series a-1, b, b-1, c, d, e and f) 0.0001 par value...
      		                             
        stockholders’ deficit:
      		                             
        preferred stock, no par value; 25,000,000 shares and no shares authorized at december 28, 2019 and december 29, 2018, respectively; no shares issued and outstanding at december 28, 2019 and december 29, 2018
      		                             
        common stock, 0.0001 par value...
      		                            1,000 
        additional paid-in capital
      		                            143,859,000 
        total liabilities, convertible preferred stock and stockholders’ equity
      		                         105,299,000 112,618,000 121,014,000  
        liabilities, convertible preferred stock and stockholders’ equity
      		                             
        stockholders’ equity
      		                             
        preferred stock, no par value; 25,000,000 shares and no shares authorized at september 28, 2019 and december 29, 2018, respectively; no shares issued and outstanding at september 28, 2019 and december 29, 2018
      		                             
        preferred stock, no par value; 25,000,000 shares authorized at june 29, 2019; none issued and outstanding at june 29, 2019
      		                             
        convertible preferred stock (series a-1, b, b-1, c, d, e and f), 0.0001 par value...
      		                            186,519,000 
        total stockholders’ deficit
      		                            -199,038,000 
        total liabilities, convertible preferred stock and stockholders’ deficit
      		                            38,759,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 
                                     
          cash flows from operating activities:
        		                             
          net income
        		7,315,000 105,383,000 24,319,000 34,907,000 25,682,000 6,857,000 4,216,000 12,194,000 12,197,000                     
          adjustments to reconcile net income to net cash from (used in) operating activities:
        		                             
          depreciation and amortization expense
        		11,864,000 7,468,000 6,849,000 6,731,000 6,137,000 5,680,000 5,177,000 4,599,000 4,302,000 3,605,000 1,893,000 1,392,000 1,287,000 1,285,000 891,000 795,000 507,000 466,000 455,000 451,000 445,000 430,000 402,000 374,000 371,000 356,000 332,000 289,000 245,000 
          stock-based compensation expense
        		9,952,000 9,395,000 9,136,000 9,372,000 8,958,000 10,767,000 7,944,000 7,643,000 6,870,000 5,724,000 5,188,000 4,958,000 3,921,000 2,991,000 2,704,000 2,316,000 2,310,000 1,985,000 1,973,000 1,808,000 1,112,000 698,000 700,000 631,000 385,000 282,000 295,000 220,000 57,000 
          deferred taxes
        		1,067,000         -120,000                    
          non-cash interest expense
        		4,593,000                          121,000 116,000 115,000 
          non-cash operating lease expense
        		610,000                             
          unrealized foreign currency transaction losses
        		486,000   -900,000 -573,000 945,000 -480,000 1,000 199,000 -460,000 268,000 -13,000 -137,000 -604,000 699,000 820,000 214,000 341,000 273,000 -170,000 484,000 -542,000 -392,000 -209,000 78,000 -192,000   160,000 
          loss on disposal of fixed assets
        		 0 0 0 80,000 0                        
          changes in operating assets and liabilities:
        		                             
          accounts receivable
        		-6,520,000 -3,582,000 24,148,000 37,518,000 -44,134,000 -7,841,000 -8,819,000 757,000 -18,407,000 -2,819,000 -11,135,000 -8,900,000 -10,962,000 -5,391,000 -9,156,000 -1,327,000 -5,804,000 -1,810,000 2,090,000 1,143,000 -583,000 -690,000 -1,663,000 1,713,000 422,000 -68,000 583,000 -1,935,000 -1,746,000 
          inventory
        		-3,896,000 -6,531,000 -6,902,000 3,714,000 2,003,000 4,137,000 -4,558,000 -2,319,000 -5,613,000 -7,063,000 -10,052,000 -7,354,000 -3,623,000 -1,930,000 -1,941,000 -1,227,000 -2,926,000 -930,000 -2,070,000 -1,513,000 -381,000 657,000 -988,000 -1,168,000 -241,000 -883,000 -12,000 -758,000 -2,468,000 
          prepaid expenses and other current assets
        		1,961,000 1,060,000 -5,900,000 -847,000 1,928,000 -196,000 -2,849,000 -1,641,000 -1,576,000 69,000 -2,685,000 1,399,000 -884,000 2,619,000 1,055,000 -1,241,000 88,000 -1,759,000 -183,000 -301,000 -908,000 -33,000 -412,000 -204,000 -120,000 564,000 -573,000 -158,000 417,000 
          other non-current assets
        		-155,000 -13,000 -6,000   -49,000 -76,000 0 -24,000 0 0 0 -54,000                 
          accounts payable
        		1,126,000 -2,064,000 2,455,000 -1,191,000 781,000 -3,138,000 -36,000 3,817,000 -2,039,000 416,000 2,868,000 2,645,000 1,028,000 264,000 -1,919,000 2,398,000 -4,013,000 3,864,000 288,000 1,020,000 -82,000 615,000 -2,590,000 -1,416,000 -2,411,000 2,389,000 -388,000 684,000 758,000 
          accrued expenses and other current liabilities
        		-3,105,000 6,966,000 13,141,000 2,231,000 -4,644,000 2,324,000 4,984,000 679,000 -49,000 4,993,000 5,061,000 742,000 3,454,000 3,445,000 234,000 -238,000 -4,000 2,519,000 366,000 2,170,000 -180,000 -1,372,000 2,660,000 -1,146,000 1,806,000 -501,000 2,138,000 -1,578,000 2,394,000 
          deferred revenue
        		40,000 -399,000 1,735,000 -522,000 330,000 -430,000 731,000 -612,000 108,000 -682,000        -65,000 -147,000 37,000 182,000 -1,096,000 308,000   0 -6,000 -187,000 57,000 
          operating lease liabilities
        		-805,000 -777,000 -740,000 -714,000 -664,000 -639,000 -626,000 -504,000 -496,000 -473,000 -359,000 -390,000 -352,000 -335,000 -328,000 -323,000 1,241,000             
          net cash from operating activities
        		24,533,000 34,513,000 69,573,000 91,609,000 -2,855,000 19,663,000 6,857,000 25,718,000 -3,435,000 8,304,000 -6,868,000 -5,803,000 -8,661,000 -4,035,000 -14,282,000 -9,094,000 -18,406,000 -6,648,000 -9,350,000 -5,536,000 -7,330,000 -7,138,000 -6,412,000 -8,539,000 -8,176,000 -7,264,000 -5,597,000 -12,159,000 -7,266,000 
          capital expenditures
        		-31,569,000 -15,549,000 -7,076,000 -8,971,000 -25,902,000 -12,474,000 -48,813,000 -23,403,000 -42,992,000 -41,088,000 0 -1,339,000 -897,000 -3,628,000 -3,331,000 -3,872,000 -1,014,000 -2,320,000 204,000 -190,000 -13,000 -2,000 -77,000 -185,000 -165,000 98,000 38,000 -258,000 126,000 
          free cash flows
        		-7,036,000 18,964,000 62,497,000 82,638,000 -28,757,000 7,189,000 -41,956,000 2,315,000 -46,427,000 -32,784,000 -6,868,000 -7,142,000 -9,558,000 -7,663,000 -17,613,000 -12,966,000 -19,420,000 -8,968,000 -9,146,000 -5,726,000 -7,343,000 -7,140,000 -6,489,000 -8,724,000 -8,341,000 -7,166,000 -5,559,000 -12,417,000 -7,140,000 
          cash flows from investing activities:
        		                             
          purchases of property, plant and equipment
        		-36,657,000 -15,514,000 -7,624,000 -9,075,000 -27,038,000 -13,606,000 -48,203,000 -23,763,000 -44,172,000 -41,818,000                    
          net cash from investing activities
        		-36,657,000 -15,514,000 -7,624,000 -9,075,000 -27,038,000 -13,606,000 -47,762,000 -23,763,000 -44,172,000 -41,818,000 -149,828,000 -1,380,000 -927,000  24,748,000 22,015,000 10,514,000  6,199,000 3,804,000 9,272,000 9,884,000 -23,473,000 -40,724,000 12,715,000 7,360,000 -18,765,000 -49,093,000 -3,000 
          cash flows from financing activities:
        		                             
          proceeds from issuance of common stock upon exercise of stock options
        		2,212,000 3,099,000 1,816,000 7,089,000 1,742,000 1,186,000 6,439,000 10,641,000 2,547,000 924,000 952,000 705,000 3,574,000 2,787,000 1,441,000 237,000 202,000 45,000 344,000 213,000 372,000 33,000 27,000 92,000 75,000 94,000 98,000 2,000 8,000 
          proceeds from issuance of common stock in connection with employee stock purchase plan
        		1,688,000 0 1,963,000 0 1,286,000 0 1,423,000 0 638,000 0 571,000 0 384,000 0 306,000 0 203,000 0 208,000 0 211,000 0 160,000 0 197,000     
          tax withholding payments related to net settlement of restricted stock units
        		-138,000 0                            
          net cash from financing activities
        		3,762,000 3,099,000 3,641,000 7,089,000 3,028,000 1,186,000 7,862,000 10,641,000 3,185,000 924,000 1,523,000 394,013,000 3,958,000 3,065,000 164,220,000 237,000 405,000 45,000 552,000 213,000 583,000 33,000 -179,000 75,543,000 152,000 -246,000 -2,428,000 96,094,000 -697,000 
          effect of exchange rate changes on cash and restricted cash
        		-327,000 94,000 9,000 809,000 358,000                         
          net decrease in cash and restricted cash
        		-8,689,000    -26,507,000                         
          cash and restricted cash, beginning of period
        		488,866,000 0 0 0 337,150,000                         
          cash and restricted cash, end of period
        		480,177,000 22,192,000 65,599,000 90,432,000 310,643,000                         
          supplemental disclosure of non-cash activities:
        		                             
          transfers of inventory to property, plant and equipment
        		2,831,000 2,162,000 1,266,000 976,000 1,275,000 1,215,000 1,207,000 2,166,000 1,215,000 2,350,000                    
          purchases of property, plant and equipment included in accounts payable and accrued expenses
        		1,102,000 -35,000 548,000 104,000 1,136,000 1,132,000 -610,000 360,000 1,180,000 730,000                    
          operating lease liabilities arising from obtaining right-of-use assets
        		313,000 0 471,000   0    0 -51,000                   
          finance lease liability arising from obtaining right-of-use assets
        		340,040,000                             
          purchases of property, plant and equipment included in other long-term liabilities
        		3,986,000                             
          reconciliation of cash and restricted cash:
        		                             
          cash
        		461,739,000 22,192,000 65,599,000 90,432,000 310,143,000                         
          restricted cash
        		18,438,000 0 0 0 500,000  0 0 500,000 0 -250,000 0 750,000 0 0 0 500,000 0 0 0 500,000 0 0 0 500,000     
          total cash and restricted cash shown in the statement of cash flows
        		480,177,000 22,192,000 65,599,000 90,432,000 310,643,000                         
          acquired in-process research and development expenses
        		         0                    
          non-cash interest expense and end of term accretion expense
        		 706,000 796,000 791,000 787,000 784,000 780,000 775,000 772,000 770,000 765,000 487,000 106,000  31,000 141,000 137,000  137,000 134,000 130,000  130,000 126,000 123,000     
          non-cash lease expense
        		 585,000 550,000 523,000 474,000 462,000 452,000 329,000 321,000 313,000 305,000 232,000 191,000 185,000 180,000 174,000 178,000             
          changes in operating assets and liabilities, net of acquired assets and liabilities:
        		                             
          purchase of business, net of cash acquired
        		     0    0                    
          purchase of in-process research and development assets
        		         0                    
          proceeds from issuance of convertible senior notes, net of issuance costs paid of 14,620
        		         0 0                   
          purchases of capped calls related to convertible senior notes
        		         0 0                   
          net increase in cash and restricted cash
        		 22,192,000 65,599,000                           
          supplemental disclosure of cash flow information:
        		                             
          cash paid for interest
        		                             
          conversion of convertible senior notes into common stock
        		                             
          adjustments to reconcile net income to net cash from operating activities:
        		                             
          unrealized foreign currency transaction gains
        		                             
          changes in operating assets and liabilities
        		                             
          loss on extinguishment of debt
        		             0                
          loss on sale of marketable securities
        		             0                
          net amortization of premiums on marketable securities
        		             0 12,000 141,000 228,000 281,000 308,000 376,000 391,000 330,000 255,000 48,000 1,000 -69,000 -112,000   
          purchases of marketable securities
        		             0 -988,000 -7,475,000 -2,033,000 -5,330,000 -21,233,000 -33,753,000 -11,708,000 -20,281,000 -37,875,000 -59,469,000 -4,168,000 -14,694,000 -18,732,000   
          proceeds from sales and maturities of marketable securities
        		             0 28,666,000 33,750,000 14,500,000 18,500,000 27,500,000 37,810,000 21,000,000 30,167,000 14,458,000 18,865,000 17,160,000     
          proceeds from issuance of long-term debt, net of issuance costs
        		             0                
          repayments of long-term debt
        		             0                
          proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions and issuance costs paid
        		             -160,000                
          proceeds from issuance of common stock upon exercise of warrants
        		                             
          effect of exchange rate changes on cash, cash equivalents and restricted cash
        		     -687,000 386,000 -62,000 -173,000 292,000 -177,000 5,000 73,000 454,000 -610,000 -669,000 -196,000 -304,000 -220,000 106,000 -379,000 405,000 309,000 134,000 -45,000 -165,000 -45,000 185,000 -60,000 
          net increase in cash, cash equivalents and restricted cash
        		     6,556,000 -32,657,000   -32,298,000 -155,350,000   -3,280,000 174,076,000 12,489,000 -7,683,000 3,085,000 -2,819,000 -1,413,000 2,146,000 3,184,000 -29,755,000 26,414,000 4,646,000 -315,000 -26,835,000   
          cash, cash equivalents and restricted cash, beginning of period
        		     0 0 0 395,312,000 0 0 0 201,682,000 0 0 0 26,080,000 0 0 0 25,081,000 0 0 0 20,592,000 0 0 0 20,741,000 
          cash, cash equivalents and restricted cash, end of period
        		     6,556,000 -32,657,000 12,534,000 350,717,000 -32,298,000 -155,350,000 386,835,000 196,125,000 -3,280,000 174,076,000 12,489,000 18,397,000 3,085,000 -2,819,000 -1,413,000 27,227,000 3,184,000 -29,755,000 26,414,000 25,238,000 -315,000 -26,835,000 35,027,000 12,715,000 
          reconciliation of cash, cash equivalents and restricted cash:
        		                             
          cash and cash equivalents
        		      -32,657,000 12,534,000 350,217,000 -32,298,000 -155,100,000 386,835,000 195,375,000 -3,280,000 174,076,000 12,489,000 17,897,000 3,085,000 -2,819,000 -1,413,000 26,727,000 3,184,000 -29,755,000 26,414,000 24,738,000     
          total cash, cash equivalents and restricted cash shown in the statement of cash flows
        		      -32,657,000 12,534,000 350,717,000 -32,298,000 -155,350,000 386,835,000 196,125,000 -3,280,000 174,076,000 12,489,000 18,397,000 3,085,000 -2,819,000 -1,413,000 27,227,000 3,184,000 -29,755,000 26,414,000 25,238,000     
          net decrease in cash, cash equivalents and restricted cash
        		        -44,595,000    -5,557,000                -8,026,000 
          net loss
        		         4,031,000 -25,422,000 -1,001,000 -2,636,000 -6,720,000 -7,426,000 -11,523,000 -10,562,000 -12,668,000 -12,962,000 -10,668,000 -7,917,000 -6,311,000 -5,088,000 -8,497,000 -8,852,000 -9,177,000 -8,280,000 -9,195,000 -6,895,000 
          adjustments to reconcile net loss to net cash from operating activities:
        		                             
          proceeds from issuance of long-term debt, net of issuance costs and issuance costs paid
        		                             
          proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions
        		                     0 0       
          offering costs included in accounts payable and accrued expenses
        		                         0 -1,261,000   
          purchases of property and equipment
        		           -1,380,000 -927,000 -2,764,000 -2,930,000 -4,260,000 -1,953,000 -3,178,000 -68,000 -253,000 -20,000 -2,000 -56,000 -120,000 -277,000 19,000 -33,000 -148,000 -3,000 
          transfers of inventory to property and equipment
        		           774,000 317,000 80,000 705,000 320,000 1,030,000 888,000 170,000 336,000 429,000 486,000 627,000 0 78,000 242,000 641,000 856,000 407,000 
          purchases of property and equipment included in accounts payable and accrued expenses
        		           41,000 30,000 -864,000 -401,000 388,000 939,000 858,000 272,000 63,000 7,000         
          supplemental disclosure of non-cash investing and financing activities:
        		                             
          non-cash interest and end of term accretion expense
        		                             
          deferred rent
        		                  122,000 -23,000 -23,000 44,000 266,000 361,000 262,000 -88,000 -87,000 -87,000 -87,000 
          net cash from (used) in investing activities
        		                             
          proceeds from paycheck protection program loan
        		                     0 0       
          repayment of paycheck protection program loan
        		                     0 0       
          supplemental disclosure of non-cash investing activities:
        		                             
          payments of public offering and other financing costs
        		                             
          payments of public offering costs and other financing costs
        		                      -366,000       
          change in fair value of preferred stock warrant liability
        		                         0 0 614,000 -273,000 
          conversion of convertible preferred stock to common stock upon initial public offering
        		                         0    
          reclassification of warrant liability to equity upon initial public offering
        		                         0 2,478,000   
          purchases of property and equipment included in accounts payable
        		                      -21,000 -65,000 112,000 79,000 71,000 -110,000 129,000 
          settlement of accrued financing fee
        		                         0    
          reclassification of warrants to additional paid-in capital
        		                             
          payments of initial public offering costs and other financing costs
        		                        -120,000     
          proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions
        		                         0 0   
          payments of initial public offering and other financing costs
        		                         -340,000    
          payments of initial public offering costs
        		                           -1,275,000 -705,000 
          deferred offering costs included in accounts payable and accrued expenses
        		                            1,134,000